Skip to content

Cupping therapy for hip joint pain with medical treatment A Clinical Study

A clinical trial to evaluate the efficacy of cupping with adjuvant therapy in pain management of avascular necrosis of femur head w.s.r. to Asthimajjagata Vata. - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/02/103912
Enrollment
30
Registered
2026-02-16
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M870- Idiopathic aseptic necrosis of bone

Interventions

None listed

Sponsors

parul institute of ayurved
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Confirmed diagnosed of AVN of femoral head having signs and symptoms of Presence of hip joint pain associated with reduced range of motion and gait disturbance. Patients Aged Between 18 to 60 Years AVN at Early to Mid Stages (Ficat and Arlet Stage I II) No Recent Surgical Intervention for AVN. Willingness to Participate and Give Written Informed Consent Both unilateral and bilateral AVN cases will be included under stages.

Exclusion criteria

Exclusion criteria: Age Below 18 & Above 60 years Patients who are positive for Hepatitis B HIV or VDRL. Patients known case of Sickle cell anaemia and thalassemia and any other bleeding disorders. Patients with uncontrolled diabetes and hypertension and thyroidism are excluded. Patient with Neurovascular or Neurological Disorders Patients on Anticoagulant or Immunosuppressive Therapy. Patients with severe systemic infectious diseases. Pregnancy or Lactating woman. patient diagnose with tuberculosis will be excluded. Patients with Ficat and Arlet Stage IV avascular necrosis of the Femoral head will be excluded. Patients with AVN caused by any previous hip injury or trauma will be excluded from the study. History of Recent Hip Surgery or Core Decompression Patient if Severe Anemia or Low Hemoglobin

Design outcomes

Primary

MeasureTime frame
Change in pain intensity from baseline to post-treatment, measured using the Visual Analog Scale (VAS).Timepoint: 84 days

Secondary

MeasureTime frame
Functional improvement assessed by Harris Hip Score, improvement in hip joint range of motion and gait, reduction in joint stiffness, decrease in rescue analgesic requirement, and improvement in daily activity performance.Timepoint: 84 days

Countries

India

Contacts

Public ContactDr Harish Daga

Parul institute of ayurved

harish.daga26839@ paruIuniversity.ac.in9413662079

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026